John J V McMurray Selected Research

nolomirole

1/2008

A randomised trial of a pre-synaptic stimulator of DA2-dopaminergic and alpha2-adrenergic receptors on morbidity and mortality in patients with heart failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John J V McMurray Research Topics

Disease

491	Heart Failure 11/2022 - 01/2002
104	Myocardial Infarction 01/2022 - 11/2003
77	Type 2 Diabetes Mellitus (MODY) 11/2022 - 03/2005
67	Stroke (Strokes) 01/2022 - 06/2004
57	Chronic Renal Insufficiency 11/2022 - 03/2005
53	Atrial Fibrillation 01/2022 - 03/2005
43	Left Ventricular Dysfunction 01/2021 - 11/2003
33	Systolic Heart Failure 01/2021 - 11/2007
28	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 09/2004
26	Diabetes Mellitus 01/2021 - 09/2004
25	Anemia 01/2022 - 12/2004
24	Hypotension (Low Blood Pressure) 10/2022 - 09/2003
19	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 05/2009
17	Sudden Death 01/2022 - 10/2004
17	Cardiomyopathies (Cardiomyopathy) 01/2022 - 08/2010
16	Renal Insufficiency (Renal Failure) 03/2022 - 12/2012
16	Hypertension (High Blood Pressure) 01/2022 - 06/2004
15	Hyperkalemia 03/2022 - 10/2004
15	Acute Coronary Syndrome 01/2022 - 05/2008
13	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 03/2009
12	Albuminuria 01/2022 - 07/2011
12	Dyspnea (Shortness of Breath) 01/2021 - 07/2005
11	Glucose Intolerance 12/2020 - 04/2010
10	Embolism (Embolus) 02/2015 - 03/2005
10	Hemorrhage 01/2015 - 05/2008
9	Inflammation (Inflammations) 01/2022 - 12/2009
9	Heart Diseases (Heart Disease) 01/2022 - 02/2011
9	Disease Progression 10/2021 - 08/2006
7	Kidney Diseases (Kidney Disease) 11/2022 - 04/2011
7	Heart Arrest (Cardiac Arrest) 01/2022 - 09/2004
7	Edema (Dropsy) 12/2021 - 11/2007
7	Neoplasms (Cancer) 08/2021 - 03/2005
7	Coronary Disease (Coronary Heart Disease) 12/2020 - 06/2004
7	Infarction (Infarctions) 10/2012 - 09/2004
6	Respiratory Sounds (Crackle) 01/2022 - 05/2019
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 04/2007
6	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2020 - 08/2015

Drug/Important Bio-Agent (IBA)

92	sacubitril and valsartan sodium hydrate drug combinationIBA 06/2022 - 10/2012
68	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 04/2007
62	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 10/2012
62	Valsartan (Vals)FDA Link 01/2022 - 11/2003
59	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2022 - 01/2002
58	dapagliflozinIBA 08/2022 - 01/2019
57	candesartanIBA 10/2022 - 09/2003
47	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021 - 07/2010
40	pro-brain natriuretic peptide (1-76)IBA 10/2022 - 03/2009
40	Enalapril FDA LinkGeneric 01/2022 - 01/2011
37	CreatinineIBA 04/2022 - 09/2004
36	Angiotensin Receptor AntagonistsIBA 01/2022 - 09/2003
33	Mineralocorticoid Receptor AntagonistsIBA 06/2022 - 10/2004
31	Biomarkers (Surrogate Marker)IBA 10/2022 - 07/2007
29	Eplerenone (Inspra)FDA LinkGeneric 03/2022 - 06/2009
29	Darbepoetin alfa (Aranesp)FDA Link 01/2022 - 03/2005
26	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 06/2009
26	Natriuretic PeptidesIBA 01/2022 - 03/2009
25	Rosuvastatin Calcium (Crestor)FDA Link 01/2017 - 11/2007
24	Pharmaceutical PreparationsIBA 10/2022 - 10/2004
24	paragonIBA 01/2022 - 01/2017
23	aliskiren FDA Link 08/2021 - 05/2008
21	SodiumIBA 11/2022 - 08/2015
20	Hemoglobins (Hemoglobin)IBA 01/2022 - 02/2006
19	Irbesartan FDA LinkGeneric 08/2021 - 02/2008
18	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022 - 09/2003
16	DiureticsIBA 01/2022 - 07/2010
15	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2022 - 01/2018
15	Insulin (Novolin)FDA Link 10/2022 - 09/2004
15	apixabanIBA 01/2022 - 03/2010
14	AlbuminsIBA 10/2022 - 02/2009
14	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 03/2005
13	Sodium-Glucose Transport ProteinsIBA 06/2022 - 01/2018
13	C-Reactive ProteinIBA 11/2021 - 03/2009
13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 09/2004
12	Troponin T (Troponin T1)IBA 10/2022 - 10/2011
12	AngiotensinsIBA 01/2022 - 09/2004
11	omecamtiv mecarbilIBA 05/2022 - 03/2016
10	AldosteroneIBA 06/2022 - 06/2009
10	HematinicsIBA 01/2022 - 07/2009
9	PotassiumIBA 01/2021 - 11/2007
9	Nateglinide (Starlix)FDA LinkGeneric 01/2018 - 04/2010
9	Captopril (Capoten)FDA LinkGeneric 07/2009 - 11/2003
8	Spironolactone (Aldactone)FDA LinkGeneric 03/2022 - 08/2004
8	TroponinIBA 01/2022 - 01/2011
8	SymportersIBA 10/2021 - 01/2019
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2017 - 01/2002
7	AtrasentanIBA 01/2022 - 11/2019
7	Cardiac MyosinsIBA 01/2022 - 03/2016
7	IronIBA 12/2021 - 08/2010
7	Peptides (Polypeptides)IBA 11/2021 - 11/2007
7	Renin InhibitorsIBA 04/2016 - 05/2008
6	Endothelin Receptor AntagonistsIBA 01/2022 - 11/2007
6	Trinitrotoluene (TNT)IBA 01/2021 - 11/2011
6	ReninIBA 01/2021 - 01/2011
6	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 07/2007
6	AnticoagulantsIBA 01/2019 - 09/2009
6	Digoxin (Digitek)FDA LinkGeneric 01/2018 - 05/2005

Therapy/Procedure

146	Therapeutics 11/2022 - 09/2003
12	Patient Readmission 01/2020 - 05/2006
8	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 08/2010
6	Cardiac Resynchronization Therapy 01/2022 - 06/2006
6	Resuscitation 01/2021 - 09/2004